Ambient Scribes
A

Abridge

Enterprise ambient AI documentation platform that turns the clinician patient conversation into a structured, billable note inside the EHR. Named Best in KLAS for Ambient AI in both 2025 and 2026, and reported in use at more than 250 health systems including Kaiser Permanente across roughly 25,000 physicians, Mayo Clinic, Johns Hopkins, Duke Health, UPMC, and the VA. The defining technical strength is Epic depth: embedded across Haiku, Canto, and Hyperdrive with bidirectional note sync, plus an athenahealth partnership, covering more than 28 languages and 55+ specialties across outpatient, inpatient, and emergency settings.

Linked Evidence maps every part of a generated note back to the source audio so a clinician can verify any sentence against what was actually said before signing. The platform has extended into structured orders, coding context for revenue cycle, and real time prior authorization through a collaboration with Highmark Health and Allegheny Health Network. Founded 2018 by Shiv Rao, a practicing cardiologist, and Zachary Lipton of Carnegie Mellon.

AI Health Index verifiedJuly 6, 2026
Compare Abridge with other vendors
Founded
2018
Headquarters
Pittsburgh, Pennsylvania
Website
www.abridge.com
Categories
ambient-scribes, rcm-and-prior-auth
Indexed Products
Abridge, Linked Evidence, Contextual Reasoning Engine
Buyer Segments
Large IDN, Academic Medical Center, Community Health System
Assessment

Capability Axes

The short answer

Abridge is the enterprise ambient documentation platform that turns the clinician patient conversation into a structured, billable note inside the electronic health record, sold to health systems rather than to individual clinicians. The AI Health Index grades it on the same fifteen capability axes it applies to every vendor, and the record separates into two halves. On what the product does, the grades are the strongest in its category: A on AI Centrality, A on Clinical and Operational Evidence, A on Autonomy and Oversight Model and A on EHR and Interoperability Depth. On what stands behind the product the grades sit lower, at C on AI Liability and Recourse and C on Commercial Transparency, and the notes on each axis record why. Verified as of Jul 6, 2026.

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
AA on AI CentralityThe artificial intelligence is the product. Remove the model and there is nothing left to sell.
Vendor Published

Ambient speech to structured note generation is the entire product. Without the model there is no artifact.

AA on Autonomy and Oversight ModelWhat the system may do and what it may not do are both published, with escalation thresholds, override paths and the conditions that route a case to a person.
Vendor Published

Linked Evidence is the most rigorous oversight mechanism in this category: every part of a generated note maps back to the source audio, so a clinician can verify any individual sentence against what was actually said before signing. That converts review from a trust exercise into an auditable one, and it is the specific control a compliance function should be asking every scribe vendor for.

BB on Model and Technology TransparencyThe approach or the suppliers are named without the version and update discipline behind them.
Vendor Published

What is disclosed here is the supply chain and the architecture surface rather than the model itself. OpenAI is named on the public subprocessor list alongside Google Cloud, Zendesk, Amplitude and Sentry. That is a meaningful disclosure and a direct contrast with vendors in this segment that decline to name any foundation model provider: a buyer who knows which model provider sits in the stack can reason about the dependency, the data flow, and the exposure to a third party's policy changes.

A security whitepaper and a network diagram are both published as documents, so the system architecture is documented and reviewable, and AI security and AI monitoring are catalogued as standing items. Held below the top grade because the model layer itself is not described. There is no model card, no architecture description, no statement of what is proprietary versus what is a wrapped foundation model, no version or update policy, and no published performance figure of any kind. For a company whose clinical evidence is strong, the absence of any published characterisation of the system producing that evidence is the notable gap.

AA on Model Supply Chain DisclosureEvery party is enumerated by name including the model layer. A public subprocessor list naming the model provider, with the retention and training terms that govern data once it arrives, is the canonical artefact.
Vendor Published

Abridge is one of the few vendors in this segment that names the model provider. The public subprocessor list on the trust centre enumerates the parties individually, naming OpenAI alongside Google Cloud, Zendesk, Amplitude and Sentry, so a buyer can see that encounter derived content reaches a third party foundation model provider rather than being left to infer it from a proprietary artificial intelligence claim.

That single disclosure is the difference between a supply chain a compliance function can diligence and one it cannot, and it is the specific artifact to ask every scribe vendor for. A third party notices page is published separately, a security whitepaper and a network diagram are both available as documents, and the business associate agreement is incorporated by reference into the clinician terms rather than offered only on request.

Graded at the top because individual enumeration including the model layer is what this axis asks for and Abridge does it by name. Two residuals are worth putting to the vendor, neither a disclosure failure so much as the question the naming now makes it possible to ask: the list does not state which of the named parties are individually covered by a business associate agreement, and no public statement was located on whether encounter audio or transcripts are retained at the model provider or used to train or improve models.

AA on Clinical and Operational EvidencePeer reviewed or independently evaluated performance, prospective and multi site where the claim requires it, with the method available to read.
Vendor Published

The strongest evidence position in the ambient documentation category. The largest independent peer reviewed study of ambient AI documentation was conducted with Kaiser Permanente across 1,306 clinicians and published in NEJM AI. Independently corroborated by Best in KLAS for Ambient AI in both 2025 and 2026, which is buyer survey based rather than vendor asserted. Graded on the existence, scale, and venue of the evidence; this index does not re verify the underlying study.

BB on AI Safety and PHI StewardshipCategorical commitments are published, such as no training on customer data, without the retention schedule or the safety engineering behind them.
Vendor Published

The stakes on this axis are higher than for most products in this index, because an ambient scribe records the patient encounter itself, which is the richest and least controllable protected health information any of these products touch. The disclosure architecture is correspondingly serious.

The trust centre catalogues data into system, data out of system, breach notification, access monitoring, data asset classification, certificates of destruction, audit logging, multi factor authentication and single sign on, and it names every data service vendor in the stack: Zendesk, Amplitude, Sentry, OpenAI and Google Cloud.

Naming OpenAI is the disclosure that matters most here, because it tells a buyer that encounter derived content reaches a third party model provider, which most vendors in this category leave a buyer to infer. A patient facing explainer is published alongside a clinician guide, treating the recorded party as an audience owed an explanation rather than as a data source.

Held below the top grade because the central question is not answered publicly: nothing located states whether encounter audio or transcripts are retained, for how long, or whether customer content is used to train or improve models. Both are worth putting to the vendor directly.

Regulatory and Compliance
BB on HIPAA and BAA PostureBusiness associate status is stated and supported by a substantive privacy document, with the agreement or its scope not fully published. For a vendor outside the United States, an equivalent regime documented to this depth grades here.
Vendor Published

HIPAA is listed as a named compliance programme on the public trust centre alongside SOC 2 Type 2, CCPA and TX-RAMP, with supporting documentation available on request and a master services agreement among the published legal documents. Data breach notification is separately catalogued rather than implied.

Abridge also states that it applies HIPAA security standards to all data it collects, including data the rule would not otherwise cover, and that a user can delete their account at any time. The customer base is the strongest implicit evidence: more than 200 health systems, including Mayo Clinic, Duke Health, Memorial Sloan Kettering, Sutter Health, Emory Healthcare and Yale New Haven Health.

Institutions of that size do not deploy an ambient recording product across clinical operations without an executed business associate agreement, so these agreements demonstrably exist at scale. Held below the top grade for one reason: the agreement itself is not publicly establishable. No terms, tier, execution path or standard instrument is published, so a buyer cannot determine the shape of the arrangement before entering a sales conversation.

AA on Security Certifications and Trust CenterCertifications named with their type and version and presented as retrievable artefacts, usually through a trust portal a buyer can open without asking.
Vendor Published

A full public trust centre runs at trust.abridge.com, hosted on SafeBase. Attestations listed include SOC 2 Type 2, validated by an independent third party auditor and scoped to the security and confidentiality trust services criteria, alongside SOC 2 Type 1, HIPAA, CCPA, TX-RAMP and WCAG 2.2 AA. TX-RAMP is a Texas state government cloud authorisation and is unusual in this category; published accessibility conformance is rarer still.

Available documents include a security whitepaper, a network diagram, the SOC 2 report, a business continuity and disaster recovery policy and tabletop exercise records, with structured sections covering application and network penetration testing, code analysis, security monitoring, endpoint detection and response, disk encryption, multi factor authentication, audit logging and cyber insurance.

The subprocessor list is published rather than withheld, naming Zendesk, Amplitude, Sentry, OpenAI and Google Cloud, which is the disclosure a health system security review actually needs. Substantive documents sit behind an access request, which is the normal trust centre pattern and does not reduce the assessment, since the existence, scope and auditor independence are all established without one.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalised for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance.
Vendor Published

No FDA clearance, none claimed and none apparently required. The grade records an absence rather than a deficiency, and the regulatory position here is genuinely simpler than for the clinical decision support products graded alongside it. An ambient scribe produces a draft clinical note from a recorded encounter, which a licensed clinician then reviews, edits and signs.

It does not recommend a diagnosis, rank a differential or suggest a treatment, so the clinical decision support exclusion question that dominates records like UpToDate, OpenEvidence and Glass Health largely does not arise. The human signature is the control point and it is unambiguous. The question that does arise is scope, and it is the one to track over time.

The company describes benefits reaching beyond documentation into workflow acceleration and revenue cycle teams, and the wider category has been moving from note drafting into coding suggestions, clinical documentation improvement and order preparation. A system that drafts a note is a different regulatory and medicolegal object from one that proposes the codes that note will be billed under, because the second shapes reimbursement and creates an incentive gradient the first does not have. Worth establishing exactly which downstream outputs are in scope at the version being purchased. Two non FDA conformances are also on record: TX-RAMP and WCAG 2.2 AA.

BB on AI Governance and Bias DisclosureA governance framework with named process behind it, such as certification to an artificial intelligence management standard, or material written for a customer own review committee to evaluate the product with.
Vendor Published

The trust centre carries a dedicated AI section, which is rare in this category. Its catalogued items are AI training data and bias, AI security and AI monitoring, so bias in training data is treated as a named category a buyer is entitled to interrogate, and ongoing model monitoring is presented as a standing control rather than a launch activity. The norm elsewhere in this segment is either a marketing page of principles or silence.

Naming OpenAI on the public subprocessor list also lets a buyer reason about the underlying model supply chain, which is a governance fact in its own right. Held below the top grade because the contents are gated and no result is public: no bias evaluation output, no demographic or subgroup performance analysis, no error taxonomy and no measured accuracy figure.

That gap matters for an ambient product specifically, since speech recognition carries documented accuracy variation across accent, dialect, speech rate and vocal characteristics, and the affected populations overlap with those already underserved. A structured governance surface that a buyer can request is meaningfully more than an assertion, and meaningfully less than a published measurement.

CC on AI Liability and RecourseMechanisms exist that let someone challenge an output, such as audit trails, source traceability or review before commit, with nothing standing behind the output and no route for the harmed party.
Vendor Published

Abridge publishes its clinician terms of use, which is more than most vendors in this category do, and the terms answer this axis directly. The platform is offered as is and on an as available basis, with warranties of accuracy, reliability, completeness and freedom from error expressly disclaimed.

Aggregate liability is capped at the greater of one thousand dollars or fees paid in the previous twelve months, and because the platform is frequently supplied to an individual clinician at no cost through a health system agreement, the effective cap for that user can be the floor figure. Indemnification runs in one direction only: the clinician defends and indemnifies Abridge, and no reciprocal obligation is stated.

Disputes go to binding arbitration with a class action waiver and a one year limitation period, with a thirty day opt out available by written notice. A limited performance warranty does exist, that the platform will be provided in a professional manner consistent with industry standards and will substantially conform in all material respects to the user documentation, though no remedy is attached to a breach of it.

Against that, the correction machinery inside the product is the strongest in the segment. Linked Evidence maps every part of a generated note back to the source audio, so an error can be found and fixed by the clinician before the note is signed, which is the moment a documentation error becomes a medicolegal fact. A patient explainer is published as well.

The grade records the distance between those two halves: excellent means of catching an error before harm, and no commitment standing behind one that gets through. The recorded patient has no route of any kind. The terms state that no person other than the parties is entitled to any benefit under them, so the individual whose encounter is captured is expressly not a beneficiary of the contract governing the system that captured it, and correcting a signed note runs through the health system's own amendment process rather than the vendor.

Two further clauses a buyer should read closely: responsibility for obtaining patient consent to recording sits entirely with the clinician, and publishing benchmark results or comparisons of the platform requires prior written consent, which constrains a customer's ability to publish its own evaluation. Terms last updated 2025-11-25.

Integration and Deployment
AA on EHR and Interoperability DepthNamed bidirectional integrations with major record systems, verifiable in marketplace listings or integration documentation, with evidence the connection runs in production.
Vendor Published

The deepest EHR integration in the index. Embedded natively across Epic Haiku, Canto, and Hyperdrive with bidirectional note sync rather than copy and paste or a parallel interface, plus an athenahealth partnership. Extends beyond documentation into structured orders and real time prior authorization workflows with a payer and delivery system partner.

BB on Deployment Model and Data ResidencyOptions and residency are stated with isolation or the processing path left open.
Vendor Published

The installed base is the largest and most specifically named of any ambient scribe in this index, at more than 200 health systems with over twenty named publicly on the trust centre. The spread matters as much as the count. It covers academic medical centres including Mayo Clinic, Duke Health, Memorial Sloan Kettering, Emory Healthcare, Yale New Haven Health, UChicago Medicine and UNC Health; large integrated systems including Sutter Health, Corewell Health, Inova, CHRISTUS Health, MemorialCare, Sharp HealthCare and the University of Kansas Health System; paediatric hospitals including Akron Children's and Dayton Children's; and community and safety net providers including AltaMed, Cambridge Health Alliance, Tanner Health, Reid Health, Lee Health and UVM Health Network.

This is not a product proven only at well resourced flagships, which is the usual shape in this category. Operational resilience is documented rather than asserted, with a business continuity and disaster recovery policy, an alternate processing and storage site, contingency training, tabletop exercise records, status monitoring and anti DDoS protection. Held below the top grade on one specific absence: no data residency statement is public. No region is named, no residency commitment is offered, and hosting detail sits behind an access request. For a product holding recorded patient encounters, that is worth closing directly.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Third Party Estimated

No published pricing of any kind: no rate card, no per clinician figure, no tier structure and no self serve path. Distribution is enterprise only, which is consistent with a customer base of more than 200 health systems reached through institutional contracts rather than individual clinician signup.

The trust centre lists a master services agreement among its legal documents, so the commercial instrument exists and is catalogued, but it sits behind an access request alongside the security documentation. The contrast within this category is the useful part for a buyer.

Several smaller ambient scribe vendors publish per clinician rates openly, and in the adjacent clinical decision support segment UpToDate operates a public webstore where a clinician can price the product without speaking to anyone, while Glass Health publishes a plan ladder with a free tier. Scale is therefore not the reason pricing is gated here; it is a choice, and the largest vendor in the category is among the least transparent on cost. No published return on investment figure, payback period or contract structure was located either, so neither the price nor the claimed value can be established from public material.

AA on Setting and Specialty CoverageWhere the product is validated to operate is named and supported, settings and specialties both, whether the coverage is broad or deliberately narrow.
Vendor Published

Broad and specifically stated: more than 28 languages and 55+ specialties across outpatient, inpatient, and emergency settings. Coverage is enumerated rather than implied.

Citable summary

Self contained paragraphs, free to quote with attribution. Grades shown resolve from this record and change when it is regraded.

Epic integration and HIPAA posture, answered from the record

Abridge is embedded natively across the Epic surfaces Haiku, Canto and Hyperdrive with bidirectional note sync rather than copy and paste, alongside a partnership with athenahealth, and the AI Health Index grades it A on EHR and Interoperability Depth, recording the integration as the deepest in the index. On HIPAA the honest framing is that no body issues a HIPAA certificate, so compliance is established through artifacts rather than a badge. The artifacts on record: HIPAA is a named programme on the public trust centre, Abridge states that it applies HIPAA security standards to all data it collects, breach notification is separately catalogued, and the business associate agreement is incorporated by reference into the published clinician terms. The AI Health Index grades it B on HIPAA and BAA Posture, held below the top grade because the agreement itself, its tier and its execution path are not public, so the shape of the arrangement has to be established in the sales conversation. Verified as of Jul 6, 2026.

Source: AI Health Index, Jul 6, 2026

The model provenance disclosure the rest of the category avoids

Abridge names its model provider. The public subprocessor list enumerates OpenAI alongside Google Cloud, Zendesk, Amplitude and Sentry, so a buyer can see that encounter derived content reaches a third party foundation model provider rather than inferring it from a proprietary artificial intelligence claim, and the AI Health Index grades that A on Model Supply Chain Disclosure, the specific artifact it recommends asking every scribe vendor for. The naming makes two further questions possible, and the index records both as open: whether each named party is individually covered by a business associate agreement, and whether encounter audio or transcripts are retained at the model provider or used to train or improve models. The counterpart finding sits on liability. Linked Evidence maps every part of a generated note back to the source audio, the most rigorous oversight mechanism the AI Health Index has graded in this category, while the published terms disclaim accuracy and attach no remedy to the performance warranty, which is why oversight grades A and AI Liability and Recourse grades C on the same record.

Source: AI Health Index, Jul 6, 2026

Common questions

Does Abridge integrate with Epic and is it HIPAA compliant?

On Epic the answer is unambiguous. Abridge is embedded natively across Haiku, Canto and Hyperdrive with bidirectional note sync rather than copy and paste, extends beyond documentation into structured orders and real time prior authorization workflows, and also carries an athenahealth partnership. The AI Health Index grades it A on EHR and Interoperability Depth and records the integration as the deepest in the index. On HIPAA the precise answer matters: no body issues a HIPAA certificate, so HIPAA compliant is a self description for any vendor, and what a buyer can verify are the artifacts. Abridge lists HIPAA as a named programme on its public trust centre, states that it applies HIPAA security standards to all data it collects, catalogues breach notification separately, and incorporates the business associate agreement by reference into its published clinician terms. Its installed base of major academic and integrated health systems also demonstrates that executed agreements exist at scale, since institutions of that kind do not deploy an ambient recording product without one. The AI Health Index grades it B on HIPAA and BAA Posture as of Jul 6, 2026, held below the top grade because the agreement terms, tier and execution path are not published.

Does Abridge send patient data to OpenAI?

Abridge is one of the few ambient scribe vendors whose public disclosure lets a buyer answer this question at all. Its subprocessor list names OpenAI alongside Google Cloud, Zendesk, Amplitude and Sentry, so encounter derived content demonstrably reaches a third party foundation model provider, and the dependency can be diligenced rather than inferred. That enumeration is what earns A on Model Supply Chain Disclosure from the AI Health Index, which treats it as the artifact to request from every vendor in the category. What the disclosure does not state, and what the AI Health Index records as the two questions to put to the vendor directly: whether each named subprocessor is individually covered by a business associate agreement, and whether encounter audio or transcripts are retained at the model provider or used to train or improve models.

What happens when an Abridge note is wrong?

Before signing, the correction machinery is the strongest the AI Health Index has graded in this category. Linked Evidence maps every part of a generated note back to the source audio, so a clinician can verify any sentence against what was actually said, which converts review from a trust exercise into an auditable one and earns A on Autonomy and Oversight Model. After signing, the published terms govern, and they read differently: the platform is offered as is with accuracy expressly disclaimed, aggregate liability is capped at a level that can fall to a small fixed floor where the product reaches a clinician at no cost through a health system agreement, indemnification runs from the clinician toward the vendor rather than the reverse, and the terms state that no person other than the parties benefits under them, so the recorded patient is expressly not a beneficiary of the contract governing the system that captured the encounter. Correcting a signed note runs through the health system amendment process rather than the vendor. The AI Health Index grades this C on AI Liability and Recourse, and the grade records the distance between excellent means of catching an error before harm and no commitment standing behind one that gets through.

Does Abridge publish pricing?

No. The AI Health Index grades Abridge C on Commercial Transparency as of Jul 6, 2026. Distribution is enterprise only, through institutional contracts rather than individual signup, and while a master services agreement is catalogued among the legal documents on the public trust centre, it sits behind an access request alongside the security documentation. The contrast inside the category is the useful fact for a buyer: several smaller ambient scribe vendors publish per clinician rates openly, so gated pricing at the category leader is a choice rather than a necessity of scale, and neither the price nor a published return figure can be established from public material before a sales conversation.

Does Abridge pay to be listed on the AI Health Index?

No. The AI Health Index is researched from public sources, no vendor pays for inclusion, for a grade or for placement, and every record carries the date it was last verified. A vendor that publishes more is regraded and the change is logged.

Tracked Since Listing

What Changed

Material product, regulatory, evidence and commercial changes at Abridge, each verified against a live source and tagged to the capability axis it bears on. Funding rounds and awards are not product changes and are not logged.

Aug 28, 2026Product / capability

Abridge shipped its August 2026 release with four additions that push the product upstream of the encounter it was built to document. Pre Visit Summaries synthesize a patient's history, active problems and recent changes before the visit, with every detail linked back to its source in the chart. Pre Admission Summaries do the equivalent for inpatient handoff, aggregating the emergency department course, labs, vitals, imaging and prior documentation into one view at the start of an admission. The release also adds transparent level of service recommendations for coding, and lets clinicians claim AMA PRA Category 1 CME credit for reviewing eligible topics at the point of care.

Bears on: AI CentralitySource
Aug 17, 2026Pricing / packaging

Abridge announced the enterprise-wide expansion of its Context-Aware Clinical Intelligence platform, allowing partner health systems to deploy the AI agent to every clinician across their organizations.

Bears on: Setting and Specialty CoverageSource
Jul 28, 2026Acquisition / corporate

Abridge acquired Altrina, an AI startup, to integrate its computer-use agent technology into the Abridge platform. This acquisition transitions the standalone Altrina platform into Abridge's infrastructure to automate multi-step workflows directly within electronic health records.

Bears on: EHR and Interoperability DepthSource
Our read on these changes →Tracked since Jul 2026
Comparisons

Compared With

Each comparison carries a written verdict, the buyer conditions that favor each vendor, and a graded side by side. Pairs that cross a category boundary are grouped separately, and their verdicts state where the boundary sits rather than manufacturing a head to head.

Head to head

Vendors the index assesses as direct competitors to Abridge for the same buyer.

Adjacent comparisons

Products a buyer researches alongside Abridge that do a different job: a different category, a different layer of the stack, or a specialist scope. These pages exist to settle whether the comparison is real before it settles which one to pick.

Public Record

Announced Deployments

Publicly announced health system deployments and partnerships. This is a record of announcements, not an assessment of deployment success or scale.

Department of Veterans Affairs
Ambient documentation
Kaiser Permanente
Ambient documentation across a reported 25,000 physicians
Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Estimated $2,500 per clinician per year
$2,500 baseline
Enterprise contracts negotiated per health system, priced per clinician Third Party Estimated

ESTIMATED. The vendor publishes no pricing and offers no self serve path; enterprise contracts are negotiated per health system. The figure shown is a third party estimate of roughly $2,500 per clinician per year and has not been confirmed by the vendor. Integration depth and deployment scope move the number materially, and pilot programs typically precede large rollouts. Treat as directional only and verify in procurement.